Skip to main content

Cognition

3
Pipeline Programs
12
Companies
9
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

10 companies ranked by most advanced pipeline stage

Sandoz
SandozAustria - Kundl
1 program
1
0,5 mg FingolimodPhase 41 trial
Active Trials
NCT02575365Terminated4Est. Jan 2017
Astellas
AstellasChina - Shenyang
1 program
1
SolifenacinPhase 41 trial
Active Trials
NCT01126424Completed26Est. Dec 2010
AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
1
AZD1446Phase 11 trial
Active Trials
NCT01044342Completed20Est. Apr 2010
GSK
GSKLONDON, United Kingdom
2 programs
Beverage powder fortified with micronutrients and Bacopa monnieri extractN/A
Test beverage powderN/A1 trial
Active Trials
NCT02177942Completed528Est. Jun 2015
ViiV Healthcare
ViiV HealthcareNC - Durham
2 programs
Beverage powder fortified with micronutrients and Bacopa monnieri extractN/A
Test beverage powderN/A
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Behavioral measuresN/A1 trial
Active Trials
NCT01212029Completed159Est. Oct 2024
Cognition Therapeutics
Cognition TherapeuticsPA - Pittsburgh
1 program
Beverage powder fortified with micronutrients and Bacopa monnieri extractN/A1 trial
Active Trials
NCT02416245Completed310Est. Mar 2015
Lumos Pharma
Lumos PharmaTX - Austin
1 program
Digital Program 1N/A1 trial
Active Trials
NCT05912556Active Not Recruiting816Est. May 2025
Young BioPharma
Young BioPharmaMA - Lowell
1 program
Neuropsychological TestingN/A1 trial
Active Trials
NCT00188331Completed441Est. Sep 2015
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
adaptive cognitive trainingN/A1 trial
Active Trials
NCT06524388Enrolling By Invitation120Est. Jun 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Sandoz0,5 mg Fingolimod
AstellasSolifenacin
AstraZenecaAZD1446
UNION therapeuticsadaptive cognitive training
Lumos PharmaDigital Program 1
Cognition TherapeuticsBeverage powder fortified with micronutrients and Bacopa monnieri extract
GSKTest beverage powder
Human BioSciencesBehavioral measures
Young BioPharmaNeuropsychological Testing

Clinical Trials (9)

Total enrollment: 2,424 patients across 9 trials

NCT02575365Sandoz0,5 mg Fingolimod

Effect of Fingolimod on Neurodegeneration

Start: Feb 2016Est. completion: Jan 20174 patients
Phase 4Terminated
NCT01126424AstellasSolifenacin

A Study to Compare Two Medications With an Inactive Medication and Look at the Effect on a Person's Mental Ability

Start: Apr 2010Est. completion: Dec 201026 patients
Phase 4Completed
NCT01044342AstraZenecaAZD1446

A Healthy Volunteer Study to Evaluate Reversibility of Induced Impairment of Cognition

Start: Dec 2009Est. completion: Apr 201020 patients
Phase 1Completed
NCT06524388UNION therapeuticsadaptive cognitive training

Adaptive Cognitive Training on Cognitive Function in Elderly Diabetes Patients in the Community

Start: Oct 2024Est. completion: Jun 2027120 patients
N/AEnrolling By Invitation
NCT05912556Lumos PharmaDigital Program 1

Brain Response to an Intervention Using Guided, At-Home Technology for the Mind

Start: Jul 2023Est. completion: May 2025816 patients
N/AActive Not Recruiting
NCT02416245Cognition TherapeuticsBeverage powder fortified with micronutrients and Bacopa monnieri extract

Impact of Beverage Powder With Micronutrients and Brahmi Extract on Cognitive Variables in Indian School Children

Start: Jul 2014Est. completion: Mar 2015310 patients
N/ACompleted
NCT02177942GSKTest beverage powder

A Clinical Trial to Study the Impact of a Nutritional Beverage on Tests of Memory in Healthy Preschool Age Children

Start: Jun 2014Est. completion: Jun 2015528 patients
N/ACompleted
NCT01212029Human BioSciencesBehavioral measures

Testing and Calibration of Non-Invasive Optical Imaging Technology for Functional Brain Imaging

Start: Sep 2011Est. completion: Oct 2024159 patients
N/ACompleted
NCT00188331Young BioPharmaNeuropsychological Testing

Cognitive Function and Fatigue in Colorectal Cancer (CRC) Patients After Chemotherapy

Start: Nov 2003Est. completion: Sep 2015441 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

12 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.